BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34289097)

  • 21. Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010-2020-Cohort Study Based on Administrative Data.
    Datzmann T; Schmitt J; Fuhrmann S; Roessler M; Meier F; Schoffer O
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Melanoma Detected During Routine Skin Checks and Mortality.
    Watts CG; McLoughlin K; Goumas C; van Kemenade CH; Aitken JF; Soyer HP; Fernandez Peñas P; Guitera P; Scolyer RA; Morton RL; Menzies SW; Caruana M; Kang YJ; Mann GJ; Chakera AH; Madronio CM; Armstrong BK; Thompson JF; Cust AE
    JAMA Dermatol; 2021 Dec; 157(12):1425-1436. PubMed ID: 34730781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Large Skin Cancer Screening Quality Initiative: Description and First-Year Outcomes.
    Ferris LK; Saul MI; Lin Y; Ding F; Weinstock MA; Geller AC; Yuan JM; Neuren E; Maddukuri S; Solano FX; Kirkwood JM
    JAMA Oncol; 2017 Aug; 3(8):1112-1115. PubMed ID: 28241191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor.
    von Schuckmann LA; Hughes MCB; Ghiasvand R; Malt M; van der Pols JC; Beesley VL; Khosrotehrani K; Smithers BM; Green AC
    JAMA Dermatol; 2019 Jun; 155(6):688-693. PubMed ID: 31042258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening.
    Eisemann N; Waldmann A; Garbe C; Katalinic A
    Med Decis Making; 2015 Feb; 35(2):243-54. PubMed ID: 25145574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
    Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-year follow-up healthcare costs of patients diagnosed with skin cancer in Germany: a claims data analysis.
    Speckemeier C; Pahmeier K; Trocchi P; Schuldt K; Lax H; Nonnemacher M; Dröge P; Stang A; Wasem J; Neusser S
    BMC Health Serv Res; 2022 Jun; 22(1):771. PubMed ID: 35690746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Care-Based Skin Cancer Screening in a Veterans Affairs Health Care System.
    Swetter SM; Chang J; Shaub AR; Weinstock MA; Lewis ET; Asch SM
    JAMA Dermatol; 2017 Aug; 153(8):797-801. PubMed ID: 28593242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
    Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
    Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised trial of population screening for melanoma.
    Aitken JF; Elwood JM; Lowe JB; Firman DW; Balanda KP; Ring IT
    J Med Screen; 2002; 9(1):33-7. PubMed ID: 11943795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for type 2 diabetes: do screen-detected cases fare better?
    Feldman AL; Griffin SJ; Fhärm E; Norberg M; Wennberg P; Weinehall L; Rolandsson O
    Diabetologia; 2017 Nov; 60(11):2200-2209. PubMed ID: 28831538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
    Stang A; Jöckel KH
    Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
    Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
    J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin Cancer Screening: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Henrikson NB; Ivlev I; Blasi PR; Nguyen MB; Senger CA; Perdue LA; Lin JS
    JAMA; 2023 Apr; 329(15):1296-1307. PubMed ID: 37071090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study.
    Aitken CA; van Agt HME; Siebers AG; van Kemenade FJ; Niesters HGM; Melchers WJG; Vedder JEM; Schuurman R; van den Brule AJC; van der Linden HC; Hinrichs JWJ; Molijn A; Hoogduin KJ; van Hemel BM; de Kok IMCM
    BMC Med; 2019 Dec; 17(1):228. PubMed ID: 31829241
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.